Related Experiment Video
Updated: Nov 20, 2025
06:01
Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
Published on: July 26, 2024
868
Management of functional gastrointestinal disorders
1Centre for Neuroscience, Surgery and Trauma, London, UK.
Clinical Medicine (London, England)
|January 22, 2021
Summary
Functional gastrointestinal (GI) disorders, like irritable bowel syndrome, significantly impact quality of life. Effective management integrates lifestyle changes, psychological support, and medications for improved patient outcomes.
Area of Science:
- Gastroenterology and Internal Medicine
Background:
- Functional gastrointestinal (GI) disorders are prevalent, causing poor quality of life and high healthcare use.
- These conditions stem from dysregulated gut sensitivity, motility, microbiota, immune function, and central nervous system processing.
- Chronic GI symptoms are exacerbated by patient behaviors, stress, and psychological comorbidities.
Purpose of the Study:
- To outline the pathophysiology and management strategies for functional gastrointestinal disorders.
- To emphasize the importance of a comprehensive biopsychosocial approach in treating these conditions.
Main Methods:
- Review of current understanding of functional GI disorder mechanisms.
- Analysis of established and emerging treatment modalities, including pharmacological and psychotherapeutic interventions.
Main Results:
- Pharmacological treatments (antispasmodics, neuromodulators, motility agents, antidepressants) demonstrate efficacy.
- Psychotherapy is equally effective in motivated individuals.
- A strong doctor-patient relationship enhances treatment success.
Conclusions:
- Functional GI disorders require a multifaceted treatment strategy.
- Integrating lifestyle modifications, psychological support, and targeted pharmacotherapy is key.
- Optimizing the doctor-patient relationship is crucial for successful management.
Related Concept Videos
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
513
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
513
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
504
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
504
01:17Drugs for Treatment of Diarrhea-Predominant IBS
431
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
431
01:20Gastrointestinal Motility Disorders
807
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
807
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
390
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
390
01:29Inflammatory Bowel Disease IV: Pharmacological Management
301
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
301